Free Trial

BioLargo (BLGO) Competitors

BioLargo logo
$0.19 +0.01 (+3.44%)
As of 11:06 AM Eastern

BLGO vs. AMTX, VGAS, LODE, ORGN, TSE, ZTEK, ALTO, LNZA, FSI, and LOOP

Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Comstock (LODE), Origin Materials (ORGN), Trinseo (TSE), Zentek (ZTEK), Alto Ingredients (ALTO), LanzaTech Global (LNZA), Flexible Solutions International (FSI), and Loop Industries (LOOP). These companies are all part of the "chemicals" industry.

BioLargo vs. Its Competitors

BioLargo (NASDAQ:BLGO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

BioLargo has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500.

BioLargo has higher earnings, but lower revenue than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLargo$12.23M4.75-$3.50M-$0.01-18.95
Aemetis$237.89M0.72-$87.54M-$1.87-1.65

BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.92%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
BioLargo-11.45% -39.90% -22.06%
Aemetis -36.92%N/A -35.80%

0.0% of BioLargo shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 19.3% of BioLargo shares are held by company insiders. Comparatively, 14.7% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Aemetis has a consensus target price of $13.63, indicating a potential upside of 341.65%. Given Aemetis' stronger consensus rating and higher possible upside, analysts clearly believe Aemetis is more favorable than BioLargo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aemetis
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, BioLargo and BioLargo both had 1 articles in the media. Aemetis' average media sentiment score of 1.87 beat BioLargo's score of 0.46 indicating that Aemetis is being referred to more favorably in the news media.

Company Overall Sentiment
BioLargo Neutral
Aemetis Very Positive

Summary

Aemetis beats BioLargo on 9 of the 15 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLGO vs. The Competition

MetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ Exchange
Market Cap$58.11M$11.86B$9.56B$9.50B
Dividend YieldN/A1.09%2.01%3.99%
P/E Ratio-18.95N/A16.5519.98
Price / Sales4.753.44104.25101.04
Price / CashN/A14.8015.1258.97
Price / Book18.9510.834.705.87
Net Income-$3.50M$989.69M$620.50M$258.50M
7 Day Performance-0.26%-0.55%2.23%1.93%
1 Month Performance-8.45%-4.61%4.38%12.29%
1 Year Performance-28.30%-14.45%101.94%19.06%

BioLargo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLGO
BioLargo
0.4506 of 5 stars
$0.19
+3.4%
N/A-30.7%$58.11M$12.23M-18.9530
AMTX
Aemetis
2.4247 of 5 stars
$3.14
+5.4%
$13.63
+333.9%
-2.4%$173.86M$237.89M-1.68160Positive News
Upcoming Earnings
VGAS
Verde Clean Fuels
0.2598 of 5 stars
$3.28
+1.2%
N/A-26.2%$146.12MN/A-6.832Positive News
LODE
Comstock
1.3296 of 5 stars
$3.72
+0.3%
$26.00
+598.9%
+142.0%$120.59M$3.38M-31.0030Positive News
ORGN
Origin Materials
2.1053 of 5 stars
$0.75
+24.8%
$1.50
+101.2%
-21.9%$111.82M$31.28M-1.11160Positive News
High Trading Volume
TSE
Trinseo
1.3621 of 5 stars
$3.11
+7.4%
N/A+10.5%$110.69M$3.39B-0.312,950
ZTEK
Zentek
0.6097 of 5 stars
$0.92
+4.9%
N/A-10.5%$96.69M$1.22M-15.3924
ALTO
Alto Ingredients
3.26 of 5 stars
$1.24
+0.8%
$5.50
+343.5%
-21.3%$95.00M$965.26M-1.51420News Coverage
LNZA
LanzaTech Global
2.4706 of 5 stars
$0.36
+12.6%
$2.00
+455.9%
-70.9%$83.46M$49.59M-0.543Gap Up
High Trading Volume
FSI
Flexible Solutions International
2.9885 of 5 stars
$5.76
+4.2%
N/A+183.9%$72.85M$36.48M17.4640
LOOP
Loop Industries
1.9538 of 5 stars
$1.23
flat
N/A-21.3%$58.70M$10.89M-4.3990Gap Up

Related Companies and Tools


This page (NASDAQ:BLGO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners